Among the genes included in this pathway, recent studies have suggested that FANCD2, SPTA1, TYRO3, and ZNF335 genes are emerging as key players in immune response and regulating tumorigenesis [32–38], even if their role has not been studied in TME of somatotropinomas. This evidence concerns the gene TYRO3 and growth hormone-producing pituitary gland neoplasm.